Non-small-cell lung cancer | Nature Reviews Disease Primers
Frontiers | Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer | Oncology
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy | Nature Reviews Cancer
The role of vitamin D in reducing cancer risk and progression | Nature Reviews Cancer
Frontiers | Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy | Immunology
Lung cancer - The Lancet
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy | Nature Reviews Clinical Oncology
Mutant p53 as a guardian of the cancer cell | Cell Death & Differentiation
Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer: Trends in Cancer
IJMS | Free Full-Text | Inflammation-Induced Tumorigenesis and Metastasis | HTML
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy | Nature Reviews Cancer
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews
Frontiers | Bridging Tumorigenesis and Therapy Resistance With a Non-Darwinian and Non-Lamarckian Mechanism of Adaptive Evolution | Oncology
Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics: Molecular Therapy - Nucleic Acids
Frontiers | The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer | Immunology
Future directions in cancer prevention | Nature Reviews Cancer
The metastatic niche: adapting the foreign soil | Nature Reviews Cancer
Cancers | Free Full-Text | Immune-Related Mutational Landscape and Gene Signatures: Prognostic Value and Therapeutic Impact for Head and Neck Cancer | HTML
Cancers | Free Full-Text | CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy | HTML
Cancers | Free Full-Text | Current Perspectives in Cancer Immunotherapy | HTML
Kinase drug discovery 20 years after imatinib: progress and future directions | Nature Reviews Drug Discovery
Cancer-associated fibroblasts—heroes or villains? | British Journal of Cancer
Frontiers | Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer | Oncology
Cancers | Free Full-Text | Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer | HTML
Cancers | Free Full-Text | Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment | HTML
